Wendy M Novicoff1, Khaled J Saleh. 1. Departments of Orthopaedic Surgery and Public Health Sciences, University of Virginia School of Medicine, Box 80015, HSC, Charlottesville, VA 22908, USA. wmn2v@virginia.edu
Abstract
BACKGROUND: Total joint arthroplasty (TJA) is remarkably successful for treating osteoarthritis: most patients see substantial gains in function. However, there are considerable geographic, racial, and gender variations in the utilization of these procedures. The reasons for these differences are complex. QUESTIONS/PURPOSES: We examined sex and gender disparities in TJA. METHODS: Through Medline/PubMed searches, we identified 632 articles and from these selected 61 for our review. WHERE ARE WE NOW?: A number of factors might explain sex and gender disparities in TJA: underrepresentation in clinical trials, differences in willingness to undergo surgery, pain responses to underlying disease and treatment, patient-physician relationships, treatment preferences, provider-level factors such as physician-patient communication style, and system-level factors such as access to specialist care. Since women have a higher prevalence of arthritis and degenerative joint diseases and overall demand for these procedures will continue to grow, the need to understand why there is a gap in utilization based on gender is imperative. WHERE DO WE NEED TO GO?: Understanding what exactly is meant by "disparity" is essential because it is possible anatomic factors may have different impacts on utilization from cultural factors. Ideally, information about these factors should be integrated into the decision-making process so that patients and providers can make the most informed choice about whether or not to undergo the procedure. HOW DO WE GET THERE?: To better understand all of the potential reasons for how anatomic and cultural factors related to sex and gender might impact decision-making and overall utilization of TJA, more research focusing on these factors must be designed and carried out.
BACKGROUND:Total joint arthroplasty (TJA) is remarkably successful for treating osteoarthritis: most patients see substantial gains in function. However, there are considerable geographic, racial, and gender variations in the utilization of these procedures. The reasons for these differences are complex. QUESTIONS/PURPOSES: We examined sex and gender disparities in TJA. METHODS: Through Medline/PubMed searches, we identified 632 articles and from these selected 61 for our review. WHERE ARE WE NOW?: A number of factors might explain sex and gender disparities in TJA: underrepresentation in clinical trials, differences in willingness to undergo surgery, pain responses to underlying disease and treatment, patient-physician relationships, treatment preferences, provider-level factors such as physician-patient communication style, and system-level factors such as access to specialist care. Since women have a higher prevalence of arthritis and degenerative joint diseases and overall demand for these procedures will continue to grow, the need to understand why there is a gap in utilization based on gender is imperative. WHERE DO WE NEED TO GO?: Understanding what exactly is meant by "disparity" is essential because it is possible anatomic factors may have different impacts on utilization from cultural factors. Ideally, information about these factors should be integrated into the decision-making process so that patients and providers can make the most informed choice about whether or not to undergo the procedure. HOW DO WE GET THERE?: To better understand all of the potential reasons for how anatomic and cultural factors related to sex and gender might impact decision-making and overall utilization of TJA, more research focusing on these factors must be designed and carried out.
Authors: P R Fortin; A E Clarke; L Joseph; M H Liang; M Tanzer; D Ferland; C Phillips; A J Partridge; P Bélisle; A H Fossel; N Mahomed; C B Sledge; J N Katz Journal: Arthritis Rheum Date: 1999-08
Authors: K A Schulman; J A Berlin; W Harless; J F Kerner; S Sistrunk; B J Gersh; R Dubé; C K Taleghani; J E Burke; S Williams; J M Eisenberg; J J Escarce Journal: N Engl J Med Date: 1999-02-25 Impact factor: 91.245
Authors: Peter Cram; Gillian Hawker; John Matelski; Bheeshma Ravi; Andrew Pugely; Rajiv Gandhi; Timothy Jackson Journal: J Racial Ethn Health Disparities Date: 2017-03-24
Authors: Marion Doull; Vivian Welch; Lorri Puil; Vivien Runnels; Stephanie E Coen; Beverley Shea; Jennifer O'Neill; Cornelia Borkhoff; Sari Tudiver; Madeline Boscoe Journal: PLoS One Date: 2014-11-05 Impact factor: 3.240
Authors: Vivian A Welch; Elie A Akl; Gordon Guyatt; Kevin Pottie; Javier Eslava-Schmalbach; Mohammed T Ansari; Hans de Beer; Matthias Briel; Tony Dans; Inday Dans; Monica Hultcrantz; Janet Jull; Srinivasa Vittal Katikireddi; Joerg Meerpohl; Rachael Morton; Annhild Mosdol; Jennifer Petkovic; Holger J Schünemann; Ravi N Sharaf; Jasvinder A Singh; Roger Stanev; Thomy Tonia; Mario Tristan; Sigurd Vitols; Joseph Watine; Peter Tugwell Journal: J Clin Epidemiol Date: 2017-04-12 Impact factor: 6.437
Authors: Asimina Lazaridou; Alexandra Koulouris; Kathleen Dorado; Peter Chai; Robert R Edwards; Kristin L Schreiber Journal: Int J Yoga Date: 2019 Sep-Dec